| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/24/2008 | US20080095754 Epithelium cell stabilizer component comprising diglycine, triglycine, tetraglycine and/or pentaglycine for use in treatment of dry eye |
| 04/24/2008 | US20080095752 Increasing durability and storage stability of powdered milk, baby food and infant formula comprising lactobacillus via reduction in threshold water content |
| 04/24/2008 | US20080095742 Composition for Treating Virus Infection Disease Comprising Jab1 |
| 04/24/2008 | US20080095741 Using reduced lipoic acid as tool in treatment of pancreatic disorders; antidiabetic agents |
| 04/24/2008 | US20080095740 4-piperazine-4-piperidine-1-ketone derivatives; graft v. host disease, arthritis, rheumatoid arthritis, inflammatory bowel disease, atopic dermatitis, psoriasis, asthma, allergies or multiple sclerosis; human immunodeficiency viricides |
| 04/24/2008 | US20080095739 Heterocyclic antiviral compounds |
| 04/24/2008 | US20080095736 Biocompatible polymers and hydrogels and methods of use |
| 04/24/2008 | US20080095735 Skin-Protective Polymer For Use In Teat Care Compositions |
| 04/24/2008 | US20080095731 Personal Care Compositions Comprising Alpha-Glucans and/or Beta-Glucans |
| 04/24/2008 | US20080095729 Aqueous fatty quaternary amine-containing systems for water-insoluble materials |
| 04/24/2008 | US20080095720 Skin Benefit Compositions with a Vanilloid Receptor Antagonist |
| 04/24/2008 | US20080095718 Atomizing a phosphodiesterase inhibitor, receptor agonists of dopamine, melaocortin, or growth hormone-releasing peptide, or an alpha-adrenoceptor antagonist; with a hand-held delivery device; increased bioavailability; side effect reduction |
| 04/24/2008 | US20080095717 Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics |
| 04/24/2008 | US20080095711 Modulators of Pulmonary Hypertension |
| 04/24/2008 | US20080095708 Biphenyl compounds useful as muscarinic receptor antagonists |
| 04/24/2008 | US20080095707 Inhibiting the growth of tumor cells overexpressing MN protein with enzyme inhibitors of carbonic anhydrase (CA 1X) (MN protein); pyridinium derivatives of aromatic heterocyclic sulfonamides; side-effect reduction; antitumor, -carcinogenic, -metastasis agents |
| 04/24/2008 | US20080095703 Method For Checking And Controlling The Mammalian Lactic Acid Fermentation Process / Aerobic Glucose Fermentation Metabolic Pathway In Mammalian Organism |
| 04/24/2008 | US20080095702 Method for monitoring blood flow and metabolic uptake in tissue with radiolabeled alkanoic acid |
| 04/24/2008 | US20080094573 Surface-modified materials, such as contact lenses, methods and kits for their preparation, and uses thereof |
| 04/24/2008 | DE202007004981U1 Zusammensetzung, insbesondere für die topische Behandlung von Hauterkrankungen Composition, particularly for topical treatment of skin diseases |
| 04/24/2008 | DE202007004776U1 Neue pharmazeutische Zusammensetzungen für die Lipolyse New pharmaceutical compositions for lipolysis |
| 04/24/2008 | DE102007006136A1 Z-Stilben-Derivate und das Arzneimittel davon Z-stilbene derivatives and pharmaceutical compositions thereof |
| 04/24/2008 | DE102006057580B3 New 3,4-diaminopyridine derivatives useful as catalysts in a chemical reaction including acylation reaction of alcohols, or in urethane and/or a polyurethane synthesis |
| 04/24/2008 | DE102006049821A1 New, well tolerated metal chelates, for use as radiodiagnostic, radiotherapeutic or NMR and X-ray diagnostic agents, contain chelator and perfluorinated polyethylene glycol residues |
| 04/24/2008 | DE102006049586A1 Nail varnish remover comprises urea; fatty acids; allantoin, dexpanthenol, coenzyme Q10 and/or hyaluronic acid; and solvent |
| 04/24/2008 | DE102006049585A1 Nail varnish useful for treating toenail and fingernail disorders comprises urea; fatty acids; allantoin, dexpanthenol, hyaluronic acid, penetration enhancer, antimicrobial agent, antipsoriatic agent and/or antieczema agent |
| 04/24/2008 | DE102006049580A1 Topische Zusammensetzung zur Behandlung von Ekzemen A topical composition for treatment of eczema |
| 04/24/2008 | DE102006049520A1 Verfahren zur Herstellung von Pradofloxacin Process for preparing pradofloxacin |
| 04/24/2008 | DE102006048924A1 Acylaminopyrazole Acylaminopyrazole |
| 04/24/2008 | DE102006011510A1 Combination pills for contraception and therapy, contain gestagen and phytoestrogen, and ensure good estrogen supply without causing bleeding |
| 04/24/2008 | CA2800405A1 Antidepressant, neuroprotectant, amyloid .beta. deposition inhibitor or age retardant containing heterocyclic compound having specific structure |
| 04/24/2008 | CA2800404A1 Antidepressant, neuroprotectant, amyloid .beta. deposition inhibitor or age retardant containing heterocyclic compound having specific structure |
| 04/24/2008 | CA2800331A1 Antidepressant, neuroprotectant, amyloid .beta. deposition inhibitor or age retardant containing heterocyclic compound having specific structure |
| 04/24/2008 | CA2680507A1 Compounds and methods for treatment of hcv |
| 04/24/2008 | CA2675500A1 Ophthalmic compositions comprising diglycine |
| 04/24/2008 | CA2675499A1 Ophthalmic compositions containing diglycine |
| 04/24/2008 | CA2674917A1 Process for preparing oxymorphone, naltrexone, and buprenorphine |
| 04/24/2008 | CA2674915A1 Process for preparing oxymorphone |
| 04/24/2008 | CA2673526A1 Phenylalkyl carbamate compositions |
| 04/24/2008 | CA2673487A1 Phenylalkylamino carbamate compositions |
| 04/24/2008 | CA2673125A1 Compositions and methods for inhibition of the jak pathway |
| 04/24/2008 | CA2672926A1 Bicyclic heteroaromatic compounds |
| 04/24/2008 | CA2672925A1 Escitalopram and solid pharmaceutical composition comprising the same |
| 04/24/2008 | CA2670690A1 Pharmaceutical composition in the form of coated microspheres for the modified release of a muscle relaxant and an nsaid |
| 04/24/2008 | CA2667115A1 Triglyceridic nature oil with improved nutritional properties and process for the preparation thereof |
| 04/24/2008 | CA2667055A1 Antisense compounds |
| 04/24/2008 | CA2667039A1 Multiple unit tablet compositions of benzimidazole compounds |
| 04/24/2008 | CA2666840A1 Inhibition of degradation of extracellular matrix |
| 04/24/2008 | CA2666794A1 Method and pharmacological composition for the diagnosis and treatment of male sub-fertility |
| 04/24/2008 | CA2666781A1 .alpha.-galactoceramide analogs, their methods of manufacture, intermediate compounds useful in these methods, and pharmaceutical compositions containing them |
| 04/24/2008 | CA2666780A1 Novel inhibitors of chymase |
| 04/24/2008 | CA2666769A1 2-hydroxy-2-phenyl/thiophenyl propionamides as androgen receptor modulators |
| 04/24/2008 | CA2666766A1 Compounds and methods for the modulation of toll-like receptor function |
| 04/24/2008 | CA2666765A1 Novel use |
| 04/24/2008 | CA2666762A1 Aminomethyl-4-imidazoles |
| 04/24/2008 | CA2666697A1 Block copolymer for drug conjugates and pharmaceutical composition |
| 04/24/2008 | CA2666667A1 Generating an immune response by inducing cd40 and pattern recognition receptors |
| 04/24/2008 | CA2666664A1 Sulfamoyl-containing derivatives and uses thereof |
| 04/24/2008 | CA2666657A1 Nicked or gapped nucleic acid molecules and uses thereof |
| 04/24/2008 | CA2666647A1 Substituted tetrahydropyrrolopyrazine compounds with affinity for the kcnq2/3 k+ channel and the use thereof in medicaments |
| 04/24/2008 | CA2666603A1 Therapeutic pyrazolyl thienopyridines and uses thereof for treating tgf.beta. mediated conditions |
| 04/24/2008 | CA2666590A1 Heterocyclic compounds and their use as glycogen synthase kinase 3 inhibitors |
| 04/24/2008 | CA2666581A1 Buprenorphine-containing non-pressurised spray composition for transmucosal administration |
| 04/24/2008 | CA2666508A1 Quinoline compounds |
| 04/24/2008 | CA2666406A1 Substituted sulfonamide derivatives for use as bradykinin 1 receptor modulators |
| 04/24/2008 | CA2666401A1 Acylaminopyrazoles for treating cardiovascular diseases |
| 04/24/2008 | CA2666398A1 Diclofenac gel |
| 04/24/2008 | CA2666375A1 3-aminoimidazo[1,2-a]pyridine derivatives having an sglt1- and sglt2- inhibiting action for the treatment of type 1 and type 2 diabetes |
| 04/24/2008 | CA2666360A1 An alzheimer's disease progression inhibitor containing heterocyclic compound having specific structure |
| 04/24/2008 | CA2666357A1 Enhancing disease resistance against rna viral infections with intracytoplasmic pathogen sensors |
| 04/24/2008 | CA2666219A1 Novel anxiolytic compounds |
| 04/24/2008 | CA2666116A1 Phenylacetamides useful as protein kinase inhibitors |
| 04/24/2008 | CA2665538A1 Hiv integrase inhibitors |
| 04/24/2008 | CA2665395A1 Small molecule intervention for obesity |
| 04/24/2008 | CA2665384A1 Pyrido [2, 3-d] pyrimidines and their use as kinase inhibitors |
| 04/24/2008 | CA2665381A1 Polymorphs of o-desmethyl venlafaxine succinate |
| 04/24/2008 | CA2665376A1 Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the .beta.2 adrenergic receptor |
| 04/24/2008 | CA2665255A1 Aminomethyl-2-imidazoles with affinity with the trace amine associated receptors |
| 04/24/2008 | CA2665204A1 Biphenyl sulfonyl and phenyl-heteroaryl sulfonyl modulators of the histamine h3-receptor useful for the treatment of disorders related thereto |
| 04/24/2008 | CA2664849A1 Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 04/24/2008 | CA2664275A1 Crystalline form phthalazinone derivative for use in cancer treatment |
| 04/24/2008 | CA2663954A1 Curcumin analogs, diagnostic methods and genetic markers for diagnosing and treating alzheimer's disease |
| 04/24/2008 | CA2660166A1 New imidazolone derivatives, preparation thereof as drugs, pharmaceutical compositions, and use thereof as protein kinase inhibitors, in particular cdc7 |
| 04/24/2008 | CA2652417A1 Pyridonecarboxamide derivatives useful in treating hyper-proliferative and angiogenesis disorders |
| 04/23/2008 | EP1914313A1 Method for producing cercosporamide |
| 04/23/2008 | EP1914310A2 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 04/23/2008 | EP1914237A2 Phosphonate ester antiviral compounds |
| 04/23/2008 | EP1914236A1 Novel heteroaryl alkylamide derivatives useful as bradykinin receptor modulators |
| 04/23/2008 | EP1914235A1 Chiral tetra-hydro beta-carboline derivatives and applications thereof as antiparasitic compounds |
| 04/23/2008 | EP1914234A1 Pyrido[2,3-d]pyrimidines and their use as kinase inhibitors |
| 04/23/2008 | EP1914233A1 Peripherally-selective inhibitors of dopamine-b-hydroxylase and method of their preparation |
| 04/23/2008 | EP1914232A1 N-dihydroxyalkyl-substituted 2-oxoimidazole derivative |
| 04/23/2008 | EP1914230A1 Wortmannin analogs and methods of using same |
| 04/23/2008 | EP1914229A1 Novel cercosporamide derivative |
| 04/23/2008 | EP1914227A1 Polymorphic crystal form of a indan-2-ylamino-hydroxyethyl-quinolinone maleate derivative as beta-adrenoceptor agonist |
| 04/23/2008 | EP1914224A1 Amorphous organic compound |
| 04/23/2008 | EP1914223A1 Anti-inflammatory and immunomodulatory amino acid derivatives, their preparation and use |
| 04/23/2008 | EP1913958A1 Antitumor compositions containing acetylcyclopropyl docetaxel and trastuzumab |
| 04/23/2008 | EP1913951A1 Method for the extraction of polyphenols and uses thereof |
| 04/23/2008 | EP1913948A1 Re-epithelializing pharmaceutical compositions containing xanthan gum |